Related Experiment Video
Updated: Mar 1, 2026

10:46
Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty
Published on: September 17, 2014
15.7K
[Visual outcomes after Descemet's membrane endothelial keratoplasty]
A S Gauthier1, M Castelbou1, M Saleh1
1Service d'ophtalmologie, CHU Jean-Minjoz, 2, boulevard Fleming, 25030 Besançon, France.
Journal Francais D'Ophtalmologie
|June 6, 2017
Summary
Descemet membrane endothelial keratoplasty (DMEK) significantly improves vision and quality of life for Fuchs endothelial dystrophy patients. Postoperative visual aberrations are minimal and do not impact outcomes.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Visual Rehabilitation
Background:
- Fuchs endothelial dystrophy is a progressive corneal disease affecting vision.
- Descemet membrane endothelial keratoplasty (DMEK) is a surgical option for advanced Fuchs.
- Understanding visual outcomes and quality of life post-DMEK is crucial.
Purpose of the Study:
- To evaluate visual rehabilitation and quality of life 6 months after DMEK in Fuchs patients.
- To identify factors influencing visual outcomes and patient well-being post-surgery.
- To assess postoperative optical aberrations and their impact.
Main Methods:
- Prospective study of 32 patients (35 eyes) undergoing DMEK.
- Measurements included visual acuity, endothelial cell density, pachymetry, and intraocular pressure at various intervals.
- Aberrometry, OCT, and NEI-VFQ-25 quality of life survey were performed at 6 months.
Main Results:
- Significant improvements in visual acuity, decreased pachymetry, and reduced endothelial cell density were observed.
- Intraocular pressure showed a statistically significant increase.
- Post-DMEK aberrations were higher than controls but considered negligible; no correlation with visual acuity or quality of life was found.
Conclusions:
- DMEK offers effective visual rehabilitation and enhances quality of life for Fuchs endothelial dystrophy patients.
- While higher-order aberrations exist post-DMEK, they do not compromise visual quality or patient-reported outcomes.

